ENDRA Life Sciences Inc. (NDRA) Financials

$4.64

$0.19 (-3.83%)
Last update: 04:00 PM EST
Day's range
$4.57
Day's range
$4.8
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning20182018201920192020202020212021202220222023202320242024-158668.5%-158668.5%-158669%-158669%-158669.5%-158669.5%-158670%-158670%-158670.5%-158670.5%-158671%-158671%Profit Margin
Profit Margin
Revenue
Earnings

NDRA Income statement / Annual

Last year (2024), ENDRA Life Sciences Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, ENDRA Life Sciences Inc.'s net income was -$11.51 M. See ENDRA Life Sciences Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.17 K $351.62 K $515.58 K $1.41 M
Cost of Revenue $206.17 K $275.45 K $234.26 K $224.42 K $165.25 K $115.01 K $0.00 $172.78 K $235.88 K $666.23 K
Gross Profit -$206.17 K -$275.45 K -$234.26 K -$224.42 K -$165.25 K -$115.01 K $6.17 K $178.84 K $279.70 K $743.83 K
Gross Profit Ratio 0 0 0 0 0 0 1 0.51 0.54 0.53
Research and Development Expenses $3.19 M $5.00 M $6.55 M $5.48 M $5.92 M $6.58 M $4.72 M $1.93 M $495.38 K $1.04 M
General & Administrative Expenses $7.06 M $4.70 M $5.17 M $4.94 M $5.00 M $3.86 M $3.75 M $2.75 M $1.54 M $1.22 M
Selling & Marketing Expenses $571.04 K $820.55 K $1.43 M $1.08 M $581.89 K $412.43 K $262.64 K $122.60 K $34.13 K $50.64 K
Selling, General & Administrative Expenses $7.63 M $5.52 M $6.60 M $6.02 M $5.58 M $4.27 M $4.02 M $2.87 M $1.58 M $1.27 M
Other Expenses $0.00 $0.00 -$21.53 K -$41.55 K $8.84 K -$106.90 K $0.00 $0.00 -$5.82 K $0.00
Operating Expenses $10.82 M $10.25 M $13.16 M $11.50 M $11.50 M $10.84 M $8.74 M $4.80 M $2.07 M $2.31 M
Cost And Expenses $18.14 M $10.52 M $13.16 M $11.50 M $11.50 M $10.84 M $8.74 M $4.98 M $2.31 M $2.98 M
Interest Income $0.00 $0.00 $0.00 $0.00 $232.43 $2.36 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $21.53 K $0.00 $232.43 K $2.36 M $729.24 K $0.00 $0.00 $0.00
Depreciation & Amortization $206.17 K $275.45 K $234.26 K $224.42 K $165.25 K $115.01 K $68.32 K $61.48 K $64.94 K $72.23 K
EBITDA -$11.30 M -$10.40 M -$12.94 M -$11.01 M -$11.33 M -$10.84 M -$9.02 M -$4.56 M -$1.73 M -$1.50 M
EBITDA Ratio 0 0 0 0 0 0 -1460.8 -12.98 -3.35 -1.06
Operating Income Ratio 0 0 0 0 0 0 -1460.8 -13.16 -3.48 -1.11
Total Other Income/Expenses Net $6.63 M $460.49 K -$21.53 K $267.06 K -$223.58 K -$2.46 M -$777.25 K -$750.90 K -$983.61 K -$710.64 K
Income Before Tax -$11.51 M -$10.06 M -$13.18 M -$11.23 M -$11.73 M -$13.31 M -$9.80 M -$5.38 M -$2.78 M -$2.28 M
Income Before Tax Ratio 0 0 0 0 0 0 -1586.7 -15.29 -5.38 -1.62
Income Tax Expense $0.00 $0.00 $21.53 K -$41.55 K $0.00 $0.00 $0.00 $0.00 $983.61 K $0.00
Net Income -$11.51 M -$10.06 M -$13.20 M -$11.19 M -$11.97 M -$15.55 M -$9.80 M -$5.38 M -$2.78 M -$2.28 M
Net Income Ratio 0 0 0 0 0 0 -1586.7 -15.29 -5.38 -1.62
EPS -10.25 -5.89 -4.57 -5.47 -12.47 -41.48 -43.49 -27.47 -14.21 -11.67
EPS Diluted -10.25 -5.89 -6.84 -5.47 -12.47 -41.48 -43.49 -27.47 -14.21 -11.67
Weighted Average Shares Out $1.12 M $1.71 M $1.93 M $2.05 M $959.61 K $375.00 K $225.24 K $195.75 K $195.35 K $195.35 K
Weighted Average Shares Out Diluted $1.12 M $1.71 M $1.93 M $2.05 M $959.61 K $375.00 K $225.24 K $195.75 K $195.35 K $195.35 K
Link